We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
AUM
$254M
AUM Growth
+$228M
Cap. Flow
+$234M
Cap. Flow %
92.38%
Top 10 Hldgs %
99.5%
Holding
77
New
1
Increased
Reduced
8
Closed
62

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$238M

Sector Composition

Rank Sector Weight
1 Healthcare 2.85%
2 Technology 1.31%
3 Utilities 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$230M 90.52%
+872,645
New +$238M
SYRE icon
2
Spyre Therapeutics
SYRE
$9.18B
$5.21M 2.05%
20,997
TXN icon
3
Texas Instruments
TXN
$253B
$3.32M 1.31%
32,000
VEA icon
4
Vanguard FTSE Developed Markets ETF
VEA
$238B
$3.24M 1.28%
73,284
-2,146
-3% -$97.4K
VOO icon
5
Vanguard S&P 500 ETF
VOO
$1.03T
$2.92M 1.15%
12,076
-370
-3% -$92.8K
VOE icon
6
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$2.88M 1.14%
26,356
-809
-3% -$91K
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.65M 1.04%
56,389
-1,660
-3% -$79.6K
VDE icon
8
Vanguard Energy ETF
VDE
$10.4B
$1.06M 0.42%
11,445
-336
-3% -$32.5K
BPTH
9
DELISTED
Bio-Path Holdings Inc
BPTH
$766K 0.3%
958
APEN
10
DELISTED
Apollo Endosurgery, Inc.
APEN
$747K 0.29%
119,200
-35,101
-23% -$221K
VNQ icon
11
Vanguard Real Estate ETF
VNQ
$38.6B
$738K 0.29%
9,784
-194
-2% -$14.8K
LXRX icon
12
Lexicon Pharmaceuticals
LXRX
$1.05B
$306K 0.12%
35,714
PLXP
13
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$210K 0.08%
62,673
POR icon
14
Portland General Electric
POR
$5.74B
$5K ﹤0.01%
118
AAPL icon
15
Apple
AAPL
$4.41T
$2K ﹤0.01%
56
-2,636
-98% -$113K
ABBV icon
16
AbbVie
ABBV
$440B
-345
Closed -$33K
ADBE icon
17
Adobe
ADBE
$103B
-254
Closed -$45K
AMP icon
18
Ameriprise Financial
AMP
$49.9B
-139
Closed -$24K
AMZN icon
19
Amazon
AMZN
$2.88T
-2,800
Closed -$164K
ANSS
20
DELISTED
Ansys
ANSS
-91
Closed -$13K
BAC icon
21
Bank of America
BAC
$453B
-507
Closed -$15K
BLK icon
22
Blackrock
BLK
$180B
-39
Closed -$20K
CAT icon
23
Caterpillar
CAT
$393B
-80
Closed -$13K
CMA
24
DELISTED
Comerica
CMA
-260
Closed -$23K
CNP icon
25
CenterPoint Energy
CNP
$26.7B
-43
Closed -$1K

Similar funds

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q1 2018 Portfolio in Review

As of Q1 2018, University of Texas/Texas AM Investment Management Co (UTIMCO) held 77 positions worth $254M, up 879% from $25.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $234M of net new capital in Q1 2018, opening 1 new position. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 872,645 shares worth $230M.

By sector, the portfolio is most concentrated in Healthcare at 2.9% of assets, down from 21% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was Apollo Endosurgery, Inc., an estimated $221K trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q1 2018 buy was State Street SPDR S&P 500 ETF Trust: 872,645 shares worth $230M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q1 2018 reduction was Apollo Endosurgery, Inc., cutting an estimated $221K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited ExxonMobil in Q1 2018, selling an estimated $842K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 100% of its $254M portfolio in Q1 2018.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 1 new position and closed 62 in Q1 2018.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 879% quarter-over-quarter to $254M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2018, filed 11 May 2018.